223520-70-5

Basic information

• Product Name: [1-benzyl-5-(2,2-dimethyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-3-yl)-4-(4-fluoro-benzyl)-2-hydroxy-5-oxo-pentyl]-carbamic acid tert-butyl ester
• Synonyms: [1-benzyl-5-(2,2-dimethyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-3-yl)-4-(4-fluoro-benzyl)-2-hydroxy-5-oxo-pentyl]-carbamic acid tert-butyl ester
• CAS NO: 223520-70-5
• Molecular Weight: 602.746
• Mol File: 223520-70-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [1-benzyl-5-(2,2-dimethyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-3-yl)-4-(4-fluoro-benzyl)-2-hydroxy-5-oxo-pentyl]-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: [1-benzyl-5-(2,2-dimethyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-3-yl)-4-(4-fluoro-benzyl)-2-hydroxy-5-oxo-pentyl]-carbamic acid tert-butyl ester(223520-70-5)
• EPA Substance Registry System: [1-benzyl-5-(2,2-dimethyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-3-yl)-4-(4-fluoro-benzyl)-2-hydroxy-5-oxo-pentyl]-carbamic acid tert-butyl ester(223520-70-5)

Safety Data

• Hazardous Substances Data: 223520-70-5(Hazardous Substances Data)

Upstream product

• 772-70-3 3-(4-fluorophenyl)propanoyl chloride 
• 459-31-4 3-(4-fluorophenyl)propanoic acid 
• 98760-08-8 (2R,3S)-3-[N-(tert-butyloxycarbonyl)amino]-1,2-epoxy-4-phenylbutane 
• 214286-81-4 3-(4'-fluorophenyl)propionic acid cis-(1''S,2''R)-1''-amino-2''-indanolacetonide amide 

Downstream Products

• 214286-83-6 ethyl-3--L-Phe(4-F)-L-(Tr-Gln)>-E-propenoate 
• 214286-82-5 ethyl-3--L-Phe(4-F)-L-(Tr-Gln)>-E-propenoate 
• 150609-74-8 (2R,4S,5S)-5-tert-Butoxycarbonylamino-2-(4-fluoro-benzyl)-4-hydroxy-6-phenyl-hexanoic acid 
• 150609-73-7 (1S,2'S,4'R)-<1-<4'-(4''-fluorobenzyl)-5'-oxo-tetrahydrofuran-2'-yl>-2-phenylethyl>carbamic acid tert-butyl ester 

Relevant articles and documents

Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics

The structure-based design, chemical synthesis, and biological evaluation of various ketomethylene-containing human rhinovirus (HRV) 3C protease (3CP) inhibitors are described. These compounds are comprised of a peptidomimetic binding determinant and an e